These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38143011)

  • 41. Trp53 null and R270H mutant alleles have comparable effects in regulating invasion, metastasis, and gene expression in mouse colon tumorigenesis.
    Tang J; Feng Y; Kuick R; Green M; Green M; Sakamoto N; Kurosu Y; Lin J; Cho KR; Fearon ER
    Lab Invest; 2019 Oct; 99(10):1454-1469. PubMed ID: 31148594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
    Parrales A; Ranjan A; Iyer SV; Padhye S; Weir SJ; Roy A; Iwakuma T
    Nat Cell Biol; 2016 Nov; 18(11):1233-1243. PubMed ID: 27775703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells.
    Yang L; Zhou Y; Li Y; Zhou J; Wu Y; Cui Y; Yang G; Hong Y
    Cancer Lett; 2015 Feb; 357(2):520-6. PubMed ID: 25499080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma.
    Kasinski AL; Slack FJ
    Cancer Res; 2012 Nov; 72(21):5576-87. PubMed ID: 22964582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.
    Turrell FK; Kerr EM; Gao M; Thorpe H; Doherty GJ; Cridge J; Shorthouse D; Speed A; Samarajiwa S; Hall BA; Griffiths M; Martins CP
    Genes Dev; 2017 Jul; 31(13):1339-1353. PubMed ID: 28790158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
    Ogawa S; Fukuda A; Matsumoto Y; Hanyu Y; Sono M; Fukunaga Y; Masuda T; Araki O; Nagao M; Yoshikawa T; Goto N; Hiramatsu Y; Tsuda M; Maruno T; Nakanishi Y; Hussein MS; Tsuruyama T; Takaori K; Uemoto S; Seno H
    Gastroenterology; 2020 Aug; 159(2):682-696.e13. PubMed ID: 32360551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
    Kolukula VK; Sahu G; Wellstein A; Rodriguez OC; Preet A; Iacobazzi V; D'Orazi G; Albanese C; Palmieri F; Avantaggiati ML
    Oncotarget; 2014 Mar; 5(5):1212-25. PubMed ID: 24681808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.
    Ingallina E; Sorrentino G; Bertolio R; Lisek K; Zannini A; Azzolin L; Severino LU; Scaini D; Mano M; Mantovani F; Rosato A; Bicciato S; Piccolo S; Del Sal G
    Nat Cell Biol; 2018 Jan; 20(1):28-35. PubMed ID: 29255172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DHX33 expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Tian QH; Zhang MF; Luo RG; Fu J; He C; Hu G; Zeng JS
    Biochem Biophys Res Commun; 2016 May; 473(4):1163-1169. PubMed ID: 27073163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The stiff RhoAd from mevalonate to mutant p53.
    Sorrentino G; Mantovani F; Del Sal G
    Cell Death Differ; 2018 Mar; 25(4):645-647. PubMed ID: 29511341
    [No Abstract]   [Full Text] [Related]  

  • 51. Analysis of the RNA helicase p68 (Ddx5) as a transcriptional regulator.
    Nicol SM; Fuller-Pace FV
    Methods Mol Biol; 2010; 587():265-79. PubMed ID: 20225156
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interconnection of Estrogen/Testosterone Metabolism and Mevalonate Pathway in Breast and Prostate Cancers.
    Mokarram P; Alizadeh J; Razban V; Barazeh M; Solomon C; Kavousipour S
    Curr Mol Pharmacol; 2017; 10(2):86-114. PubMed ID: 26758947
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-122-5p regulates the mevalonate pathway by targeting p53 in non-small cell lung cancer.
    Zheng YK; Zhou ZS; Wang GZ; Tu JY; Cheng HB; Ma SZ; Ke C; Wang Y; Jian QP; Shu YH; Wu XW
    Cell Death Dis; 2023 Apr; 14(4):234. PubMed ID: 37005437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis.
    Makino Y; Hikita H; Fukumoto K; Sung JH; Sakano Y; Murai K; Sakane S; Kodama T; Sakamori R; Kondo J; Kobayashi S; Tatsumi T; Takehara T
    Cancer Res; 2022 Aug; 82(16):2860-2873. PubMed ID: 35696550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
    Mallette FA; Richard S
    Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The DEAD-box RNA helicase DDX41 is a novel repressor of p21
    Peters D; Radine C; Reese A; Budach W; Sohn D; Jänicke RU
    J Biol Chem; 2017 May; 292(20):8331-8341. PubMed ID: 28348086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells.
    Thamkachy R; Kumar R; Rajasekharan KN; Sengupta S
    Mol Cancer; 2016 Mar; 15():22. PubMed ID: 26956619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased expression of the heterogeneous nuclear ribonucleoprotein K in pancreatic cancer and its association with the mutant p53.
    Zhou R; Shanas R; Nelson MA; Bhattacharyya A; Shi J
    Int J Cancer; 2010 Jan; 126(2):395-404. PubMed ID: 19609950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DDX3 localizes to the centrosome and prevents multipolar mitosis by epigenetically and translationally modulating p53 expression.
    Chen WJ; Wang WT; Tsai TY; Li HK; Lee YW
    Sci Rep; 2017 Aug; 7(1):9411. PubMed ID: 28842590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 54-kDa short variant of DHX33 functions in regulating mRNA translation.
    Su D; Yuan B; Su C; Zhang Y
    J Cell Physiol; 2019 Sep; 234(9):15308-15319. PubMed ID: 30684270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.